Skip to main content

John V. Heymach

NIH Rank #4741
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1894553Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$2.1M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#4,741
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for John V. Heymach. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing John V. Heymach as a PI. Multi-PI records show the full award amount for context.

  • 5U01CA256780-04U01
    Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
    $575.2K
    award amount
  • 5R01CA247975-05R01
    Molecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitors
    $549.2K
    award amount
  • 5R01CA234183-05R01
    Therapeutic strategies against EGFR exon 20 mutant lung cancer
    $529.6K
    award amount
  • 4P30CA016672-48P30
    Cancer Center Support Grant
    $401.1K
    award amount
  • 5P50CA070907-25P50
    Targeting Lung Cancer Vulnerabilities
    $88.8K
    award amount

Award organizations

Organizations that administered FY2024 awards listing John V. Heymach as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4741
  6. 2024
    Entered Top 25% Nationally
    Ranked #4741
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader